No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position.
Buys/Adds (2)
Two Sigma
$18.2M
added
First Eagle
$26.6M
bought
Sells/Trims (1)
Qube Research
$31.7M
sold
Top-trader positions in RELX could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Feb 19, 2026
Period ending
Dec 31, 2025
Earnings per share
EPS comparison unavailable
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Dec 31, 2025 | Feb 19, 2026 | Unavailable | - | GBP 9.59B No estimateYear ended Dec 31, 2025 · SEC filing | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
Reasonably priced and profitable.
Valuation
Quality
Growth
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace